Antibiotic choice based on hospital lab reports in transplant patients with bloodstream infection
Part of Infections clinical trials.
This study looks at whether choosing antibiotics based on local hospital lab reports (antibiograms) works well for organ transplant patients who have a single bacteria in their bloodstream. It hopes to find the best way to treat these infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have received a solid organ transplant (like kidney, liver, heart, or lung).
- Your bloodstream infection was caused by a single type of one of these bacteria: A. baumannii, Enterobacter, E. faecalis, E. faecium, E. coli, Klebsiella (any type), P. mirabilis, P. aeruginosa, Serratia, S. aureus, S. lugdunensis, or Streptococcus.
- You were hospitalized at the Fondazione IRCCS Cà Granda Policlinico in Milan between 2015 and 2023.
- You did NOT receive antibiotics within 48 hours before or after your blood culture sample was taken.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether piperacillin-tazobactam works as well as meropenem to treat bloodstream infections caused by certain E. coli or Klebsiella germs that resist common cephalosporin antibiotics. It may help you avoid a “bigger” antibiotic if the study drug is equally effective.
This trial checks if monitoring antibiotic levels in the blood can help doctors give the right dose to liver transplant patients with serious bacterial infections. The goal is to make the treatment work better.
This study tests whether giving antibiotics chosen specifically for your resistant bacteria before a liver transplant can prevent infections better than the usual standard antibiotics. It aims to improve recovery and lower the risk of serious infection after surgery.
This study looks at how doctors can best manage antibiotics for a common type of blood infection (caused by Enterobacterales bacteria like E. coli). If you join, your treatment will be carefully guided to make sure you get the right antibiotics at the right time, which may help you recover faster and prevent antibiotic resistance.
This trial tests whether switching from IV to oral antibiotics is just as effective for treating Gram-negative bloodstream infections. If you qualify, you may receive either continued IV antibiotics or switch to pills, with follow-up on your recovery and quality of life.
This trial uses a new blood test (called BV test) to help doctors decide if antibiotics should be stopped or continued for ICU patients with suspected or confirmed infections. It aims to reduce unnecessary antibiotic use while keeping patients safe.
Hear when a new Bacteremia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.